AAVXF vs REGN: Which Stock is Better?

Side-by-side comparison of ABIVAX Société Anonyme and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

AAVXF

ABIVAX Société Anonyme

$120.85

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricAAVXFREGNWinner
Market Cap$9.48B$77.77BREGN
P/E RatioN/A17.58REGN
EPS (TTM)$N/A$41.75REGN
Revenue Growth-0.5%0.0%REGN
Gross Margin100.0%45.8%AAVXF

Analyze AAVXF

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AAVXF or REGN a better investment?

Comparing AAVXF and REGN: ABIVAX Société Anonyme has a market cap of $9.48B while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AAVXF and REGN?

AAVXF (ABIVAX Société Anonyme) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AAVXF or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: AAVXF or REGN?

REGN has higher revenue growth at 0.0% vs -0.5% for AAVXF.

Which company is more profitable: AAVXF or REGN?

ABIVAX Société Anonyme (AAVXF) has higher gross margins at 100.0% compared to 45.8% for REGN.

Which is the larger company: AAVXF or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $9.48B for AAVXF.

Should I buy AAVXF or REGN in 2026?

Both AAVXF and REGN have investment merit. AAVXF trades at $120.85 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AAVXF and REGN stock?

Key differences: Market Cap ($9.48B vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.5% vs 0.0%), Gross Margin (100.0% vs 45.8%).

Popular Stock Comparisons